Watrium has pre-accepted Karo Pharma’s offer of NOK 35 per share for the 4 716 282 shares held in Weifa ASA.
Following a successful completion of the Offer Watrium will not hold any shares in Weifa. Watrium AS is represented on the Board of Directors of Weifa by Kristin L.A. Wilhelmsen. For further information, see the stock exchange notice from Weifa ASA.
